Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Piazza · SciRah

Researcher profile · Semantic Scholar

E. Piazza

Share profile

E. Piazza — researcher profile on SciRah

h-index: 21
Works: 92
Citations: 2,937

Most-cited papers

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.
C. Gridelli, F. Perrone, C. Gallo, S. Cigolari +19 more
2003Journal of the National Cancer Institute781 citations Open access
Semantic Scholar
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.
P. Maione, F. Perrone, C. Gallo, L. Manzione +130 more
2005Journal of Clinical Oncology460 citations
Semantic Scholar
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study.
G. Colucci, R. Labianca, F. di Costanzo, V. Gebbia +16 more
2010Journal of Clinical Oncology299 citations
Semantic Scholar
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer
M. di Maio, C. Gridelli, C. Gallo, L. Manzione +16 more
2004British Journal of Cancer131 citations Open access
Semantic Scholar
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials
M. di Maio, C. Gridelli, C. Gallo, F. Shepherd +16 more
2005BMC Cancer108 citations Open access
Semantic Scholar
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial
L. Celio, S. Frustaci, A. Denaro, A. Buonadonna +9 more
2010Supportive Care in Cancer107 citations Open access
Semantic Scholar
Encephalopathy with status epilepticus during sleep or continuous spikes and waves during slow sleep syndrome: a multicenter, long-term follow-up study of 117 patients.
R. Caraballo, P. Veggiotti, M. Kaltenmeier, E. Piazza +5 more
2013Epilepsy Research97 citations
Semantic Scholar
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S. Cascinu, R. Silva, S. Barni, R. Labianca +10 more
1999British Journal of Cancer92 citations Open access
Semantic Scholar
Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
S. Cascinu, R. Labianca, C. Barone, A. Santoro +29 more
2007Journal of the National Cancer Institute63 citations
Semantic Scholar
Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses
C. Gridelli, L. Frontini, F. Perrone, Ciro Gallo +10 more
2000British Journal of Cancer62 citations Open access
Semantic Scholar
Dravet syndrome: Early electroclinical findings and long‐term outcome in adolescents and adults
F. Darra, D. Battaglia, C. Dravet, Mara Patrini +9 more
2019Epilepsia55 citations Open access
Semantic Scholar
Epirubucin, cisplatin, and continuous infusion 5‐fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An italian group for the study of digestive tract cancer (GISCAD) report
A. Zaniboni, S. Barni, R. Labianca, G. Marini +6 more
199549 citations
Semantic Scholar
Pharmacokinetics of VP16-213 given by different administration methods
M. D'Incalci, P. Farina, Cristiana Sessa, C. Mangioni +7 more
2004Cancer Chemotherapy and Pharmacology44 citations
Semantic Scholar
Spinal muscular atrophy associated with progressive myoclonic epilepsy: A rare condition caused by mutations in ASAH1
G. Rubboli, P. Veggiotti, A. Pini, A. Berardinelli +11 more
2015Epilepsia42 citations Open access
Semantic Scholar
Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life
R. Palumbo, F. Sottotetti, G. Trifirò, E. Piazza +7 more
2015Drug Design, Development and Therapy40 citations Open access
Semantic Scholar
Epilepsy in patients with GRIN2A alterations: Genetics, neurodevelopment, epileptic phenotype and response to anticonvulsive drugs.
C. von Stülpnagel, M. Ensslen, R. Møller, Deb K. Pal +17 more
2017European journal of paediatric neurology36 citations
Semantic Scholar
Early phase pharmacokinetics of doxorubicin (adriamycin) in plasma of cancer patients during single- or multiple-drug therapy.
E. Piazza, M. Donelli, M. Broggini, C. Sessa +6 more
1980Cancer treatment reports33 citations
Semantic Scholar
Ceravolo
M. Cantore, G. Fiorentini, G. Luppi, G. Rosati +10 more
2004Journal of chemotherapy30 citations
Semantic Scholar
Supportive care in patients with advanced non-small-cell lung cancer
M. di Maio, F. Perrone, Ciro Gallo, R. V. Iaffaioli +15 more
2003British Journal of Cancer27 citations Open access
Semantic Scholar
Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers.
A. Sobrero, Alberto Zaniboni, G. Frassineti, C. Aschele +16 more
2000Annals of Oncology23 citations Open access
Semantic Scholar
The Path of Cicely Saunders: The “Peculiar Beauty” of Palliative Care
G. Miccinesi, A. Caraceni, F. Garetto, G. Zaninetta +16 more
2020Journal of Palliative Care21 citations
Semantic Scholar
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials.
M. di Maio, S. Signoriello, A. Morabito, A. Rossi +22 more
2012Lung Cancer20 citations
Semantic Scholar
Gait abnormalities in people with Dravet syndrome: A cross-sectional multi-center study.
R. Di Marco, A. Hallemans, Giulia Bellon, F. Ragona +13 more
2019European journal of paediatric neurology19 citations Open access
Semantic Scholar
Pharmacokinetic study of intravenous and oral idarubicin in cancer patients.
V. Tamassia, M. A. Pacciarini, E. Moro, E. Piazza +2 more
1987International journal of clinical pharmacology research19 citations
Semantic Scholar
Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study.
C. Gridelli, A. Ardizzoni, S. Barni, L. Crinò +16 more
2011Lung Cancer17 citations
Semantic Scholar
Transient blindness and seizure associated with cisplantin therapy
M. Cattaneo, V. Filipazzi, E. Piazza, E. Damiani +1 more
2004Journal of Cancer Research and Clinical Oncology17 citations Open access
Semantic Scholar
Differential pulse polarographic determination of BCNU pharmacokinetics in patients with lung cancer.
R. Russo, I. Bartošek, E. Piazza, A. M. Santi +2 more
1981Cancer treatment reports16 citations
Semantic Scholar
Chemotherapy-Induced Anemia and Oncologist Perception on Treatment: Results of a Web-Based Survey
D. Cortinovis, G. Beretta, E. Piazza, G. Luchena +11 more
2013Tumori15 citations
Semantic Scholar
Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II study.
C. Gridelli, A. Rossi, E. Barletta, N. Panza +11 more
2002Lung Cancer15 citations
Semantic Scholar
Pharmacokinetic studies in lung cancer patients
E. Piazza, Maria Teresa Cattaneo, M. Varini
1984Cancer15 citations
Semantic Scholar
Cross-over study of pharmacokinetics and haematological toxicity of 4'-epi-doxorubicin and doxorubicin in cancer patients.
A. Martini, E. Moro, M. A. Pacciarini, V. Tamassia +2 more
1984International journal of clinical pharmacology research15 citations
Semantic Scholar
The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients.
C. Gridelli, E. De Maio, S. Barbera, M. Sannicolò +8 more
2008Lung Cancer13 citations
Semantic Scholar
Randomised trial of gemcitabine versus flec regimen given intra-arterially for patients with unresectable pancreatic cancer.
M. Cantore, G. Fiorentini, G. Luppi, G. Rosati +10 more
2003Journal of experimental & clinical cancer research : CR13 citations
Semantic Scholar
Movement-activated cortical myoclonus in Dravet syndrome.
L. Canafoglia, F. Ragona, F. Panzica, E. Piazza +6 more
2017Epilepsy Research12 citations
Semantic Scholar
Dravet phenotype in a subject with a der(4)t(4;8)(p16.3;p23.3) without the involvement of the LETM1 gene.
Baran Bayindir, E. Piazza, E. Della Mina, I. Limongelli +5 more
2013European Journal of Medical Genetics12 citations
Semantic Scholar
Plasma and Tissue Distribution of Adriamycin in Patients with Pelvic Cancer
E. Piazza, N. Natale, A. Trabattoni, Cesare Mariscotti +4 more
1981Tumori12 citations
Semantic Scholar
Cisplatin-Vinorelbine Combination Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer
L. Frontini, P. Candido, M. Cattaneo, S. Zonato +10 more
1996Tumori11 citations
Semantic Scholar
Adriamycin distribution in plasma and blood cells of cancer patients with altered hematocrit.
E. Piazza, M. Broggini, A. Trabattoni, N. Natale +2 more
1981European Journal of Cancer and Clinical Oncology11 citations
Semantic Scholar
A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial.
A. Morabito, G. Daniele, R. Costanzo, A. Favaretto +16 more
2017Lung Cancer10 citations
Semantic Scholar
Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial
S. Barni, G. Rosati, S. Lonardi, N. Pella +27 more
2020Therapeutic Advances in Medical Oncology8 citations Open access
Semantic Scholar
Efficacy of the addition of cisplatin to single-agent first-line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): A joint analysis of the multicenter, randomized phase III MILES-3 and MILES-4 studies.
C. Gridelli, A. Morabito, L. Cavanna, A. Luciani +16 more
20177 citations
Semantic Scholar
Considerations on early diagnosis of carcinoma of the pancreas.
M. Elli, E. Piazza, P. Franzone, L. Isabella +2 more
2003Hepato-Gastroenterology7 citations
Semantic Scholar
A case of bullous dermatitis induced by erlotinib.
A. Oteri, M. Cattaneo, V. Filipazzi, S. Ferrario +6 more
2009The Oncologist5 citations Open access
Semantic Scholar
Single-Agent Epirubicin as Primary Chemotherapy in T2–T3, N0–N2, M0 Breast Carcinoma: 6-Year Follow-Up
S. Barni, E. Piazza, L. Frontini, M. Visini +13 more
2004Oncology5 citations
Semantic Scholar
High-versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: a 'GISCAD' phase III study. Italian Group for the Study of Digestive Tract Cancer.
R. Labianca, S. Cascinu, L. Frontini, S. Barni +15 more
1997Annals of Oncology5 citations
Semantic Scholar
Phase II Study of the Activity and Tolerability of a Combined Regimen of High-Dose Epirubicin and Cisplatin in Stage IIIb and IV Non-Small Cell Lung Cancer
M. Clerici, F. de Marinis, E. Piazza, L. Frontini +5 more
1998Tumori4 citations
Semantic Scholar
Plasma levels of cyclophosphamide in patients under polychemotherapeutic regimens.
L. Ottolenghi, L. Morasca, S. Marsoni, E. Piazza +3 more
1980Biomedicine / [publiee pour l'A.A.I.C.I.G.]4 citations
Semantic Scholar
Cisplatin in addition to single-agent first-line chemotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC): efficacy results of a joint analysis of the multicentre, randomized phase 3 MILES-3 and MILES-4 studies.
A. Morabito, L. Cavanna, A. Luciani, P. Maione +17 more
2017Annals of Oncology3 citations Open access
Semantic Scholar
Single-day regimen of palonosetron (PALO) and dexamethasone (DEX) for the prevention of emesis associated with moderately emetogenic chemotherapy (MEC): Subgroup analysis from a randomized phase III trial.
L. Celio, E. Bajetta, A. Denaro, E. Bichisao +6 more
2016Journal of Clinical Oncology3 citations
Semantic Scholar
Two-drug gemcitabine-based first-line treatment of elderly patients (pts) with small cell lung cancer (SCLC): The G-STEP program.
M. di Maio, C. Gallo, S. Barbera, A. Ceribelli +6 more
2006Journal of Clinical Oncology3 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Gridelli×14
Invite
C. Gridelli — researcher profile on SciRah
L. Frontini×13
Invite
L. Frontini — researcher profile on SciRah
C. Gallo×11
Invite
C. Gallo — researcher profile on SciRah
F. Perrone×9
Invite
F. Perrone — researcher profile on SciRah

×9

Invite

S. Barbera — researcher profile on SciRah

Invite

P. Maione — researcher profile on SciRah

Invite

M. di Maio — researcher profile on SciRah

Invite

S. Barni — researcher profile on SciRah

Invite

F. Rosetti — researcher profile on SciRah

Invite

S. Robbiati — researcher profile on SciRah

Invite

V. Gebbia — researcher profile on SciRah

Invite

R. Labianca — researcher profile on SciRah